Gastrectomy for Gastric Cancer Clinical Trials

6 recruitingLast updated: June 18, 2026

There are 6 actively recruiting gastrectomy for gastric cancer clinical trials across 5 countries. Studies span Phase 3, Not Applicable, Phase 2. Top locations include Kyiv, Ukraine, Cremona, CR, Italy, Daegu, South Korea. Updated daily from ClinicalTrials.gov.


Gastrectomy for Gastric Cancer Trials at a Glance

6 actively recruiting trials for gastrectomy for gastric cancer are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in Kyiv, Cremona, and Daegu. Lead sponsors running gastrectomy for gastric cancer studies include Ukrainian Society of Clinical Oncology, Azienda Ospedaliero-Universitaria di Parma, and First Affiliated Hospital of Zhejiang University.

Browse gastrectomy for gastric cancer trials by phase

Treatments under study

About Gastrectomy for Gastric Cancer Clinical Trials

Looking for clinical trials for Gastrectomy for Gastric Cancer? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastrectomy for Gastric Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastrectomy for Gastric Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer

Gastric CancerGastrectomy for Gastric Cancer
First Affiliated Hospital of Zhejiang University7,000 enrolled1 locationNCT07525765
Recruiting

How Epigenetic Changes in hMLH1 Connect Lab Research With Diagnosis in Gastric Cancer

Gastric CancerMLH1 Gene MutationGastrectomy+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS245 enrolled1 locationNCT06982768
Recruiting
Not Applicable

Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy

Enhanced Recovery After SurgeryGastrectomy for Gastric Cancer
Seoul National University Hospital308 enrolled10 locationsNCT06984952
Recruiting
Phase 2Phase 3

Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

Gastric CancerChemotherapyGastroesophageal Junction Adenocarcinoma+13 more
Ukrainian Society of Clinical Oncology150 enrolled2 locationsNCT06028737
Recruiting
Phase 3

Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer

Gastric CancerGastrectomy for Gastric CancerGastric Cancer Stage II+1 more
Ukrainian Society of Clinical Oncology105 enrolled2 locationsNCT06755554
Recruiting

Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)

Gastric CancerGastric AdenocarcinomaRobotic Surgery+7 more
Azienda Ospedaliero-Universitaria di Parma326 enrolled8 locationsNCT06466902